398 results on '"Frange, P"'
Search Results
2. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from FranceResearch in context
- Author
-
Rémonie Seng, Pierre Frange, Albert Faye, Catherine Dollfus, Jérôme le Chenadec, Faroudy Boufassa, Asma Essat, Tessa Goetghebuer, Elisa Arezes, Véronique Avettand-Fènoël, Jean-Joël Bigna, Stéphane Blanche, Cécile Goujard, Laurence Meyer, Josiane Warszawski, Jean-Paul Viard, H. Aumaitre, E. Froguel, F. Caby, S. Dellion, L. Gerard, F. Lucht, C. Chirouze, M. Dupon, Jl Schmit, C. Goujard, T. Allegre, B. Cazenave, G. Hittinger, P. De Truchis, J. Cailhol, C. Duvivier, A. Canestri, O. Bouchaud, M. Karmochkine, D. Salmon-Ceron, D. Zucman, E. Mortier, R. Tubiana, P.M. Girard, C. Pintado, A. Cabie, V. Rabier, P. Morlat, D. Neau, C. Genet, D. Makhloufi, S Bregigeon Ronot, J. Ghosn, V. Reliquet, P. Perré, Jl Pellegrin, C. Arvieux, C. Cheneau, L. Bernard, P. Delobel, R. Verdon, C. Jacomet, L. Piroth, F. Ajana, S. Bevilacqua, Y. Debab, A.L. Lecapitaine, L. Cotte, S. Mokhtari, P. Mercie, P. Poubeau, V. Garrait, Ma Khuong, G. Beck-Wirth, L. Blum, S. Blanche, F. Boccara, T. Prazuck, C. Barbuat, J.P. Viard, S. Stegmann-Planchard, B. Martha, J.M. Treluyer, E. Dore, C. Gaud, M. Niault, E. Fernandes, H. Hitoto, A. Compagnucci, N. Elenga, A. Faye, C. Dollfus, A. Chace, M. Levine, S.A. Martha, C. Floch-Tudal, K. Kebaïli, N. Entz-Werle, J. Tricoire, F. Mazingue, P. Bolot, P. Brazille, T. Goetghebuer, A.F. Gennotte, D. Van Der Linden, V. Schmitz, M. Moutschen, C. Crenn-Hebert, F. Habibi, A. Coursol, E. Guesdon, P.F. Ceccaldi, M. Dehlinger – Paul, E. Pannier, V. Marcou, C. Elleau, M. Achkar, M.O. Vareil, S. Couderc, C. Routier, M.A. Bouldouyre, L. Selleret, A. Chabrol, C. Bellahcene, C. Pluchart, A. Yangui, D. Vignes, A. Alissa, A. Johnson, E. Lachassinne, A. Benbara, L. Karaoui, A. Bongain, B. Yakeu, J.L. Schmit, L. Cravello, C. Hubert, P. Faucher, D. Pinquier, C. Borie, D. Rocchi, C. Brunet-Cartier, C. Briandet, J. Brouard, A. Chalvon-Demersay, M. Rajguru, K. Billiemaz, A. Fresard, A. Moulin, P. Fialaire, L. Mesnard, E. Werner, E. Vintejoux, J. Marian, S. Ranaivojaona, F. Bissuel, M. Abdelhadi, Y. Hammou, C. Genet-Villeger, Y. Hatchuel, G. Bachelard, M. Medus, J. Dendale – Nguyen, T.S. Guimard, A. Martha, M. Rouha, P. Perfezou, L. De Saint Martin, S. Jaffuel, R. Buzele, M. Gousseff, C. Cudeville, V. Vitrat, C. Michau, G. Palenzuela, M. Driessen, B. Heller-Roussin, J.M. Labaune, B. Muanza, J. Massardier, M. Partisani, I. Hau, C. Runel-Belliard, C. Brehin, K. Kebaili, M. Lalande, M. Lagree, K. Lacombe, J.-M. Molina, J. Reynes, O. Robineau, F. Raffi, A. Becker, L. Weiss, T. Allègre, G. Pialoux, F. Souala, A. Rami, C. Katlama, A. Cabié, J.-P. Viard, F. Bastides, C. Michel, D. Salmon, J-D Le Lièvre, A. Sotto, E. Rouveix, A. Naqvi, S. Brégigeon, R. Rodet, A. Simon-Coutelier, J.-L. Esnault, R. Buzelé, A. Stein, C. Godin-Colet, G. Pichancourt, P. Caraux-Paz, M Mohseni Zadeh, L. Gérard, C. Lascaux-Cametz, L. Bodard, J.-L. Pellegrin, N. Ettahar, A. Uludag, E. Rosenthal, F. Prevoteau du Clary, S. Jaureguiberry, P. Philibert, A.-L. Lecapitaine, E. Chakvetadze, H. Champagne, V. Daneluzzi, J. Goupil de Bouillé, A. Leprêtre, I. Lamaury, I. Darasteanu, B. Abraham, D. Garipuy, J.-L. Berger, J.-L. Schmit, K. Diallo, F. Gourdon, O. Vaillant, V. Gaborieau, J. Doll, D. Quinsat, L. Geffray, J.-J. Girard, D. Houlbert, V. Perronne, E. Klement, O. Antioniotti, C. Rouzioux, V. Avettand-Fenoel, O. Lortholary, S. Boucly, A. Maignan, R. Thiebaut, L. Meyer, F. Boufassa, M.A. Charles, R. Dray-Spira, C. Legeai, V. Amon, N. Benammar, R. Seng, L. Slama, P. Bonnard, C. Chakvetadze, T. L’Yavanc, J. Capeau, C. Vigouroux, S. Fellahi, J.P. Bastard, E. Oksenhendler, J.F. Bourge, V. Bajzik, D. Sereni, C. Lascoux-Combe, O. Taulera, L.V. Dien, J. Delgado, J.M. Molina, T. Saint-Marc, S. Ferret, J. Pavie, J.F. Bergmann, M. Parrinello, BLefebvre, C. Boudraa, B. Diallo, C. Lupin, S. Herson, A. Simon, N. Edeb, L. Guillevin, T. Tahi, M.P. Pietri, D. Tisne-Dessus, C. Jalbert, P. Yeni, S. Matheron, G. Pahlavan, B. Phung, N. El-Alami Talbi, Z. Ramani, G. Catalano, C. Godard, F. Boue, V. Chambrin, D. Bornarel, H. Schoen, R. Carlier, B. Fantin, C. Poder, R. Dhote, M. Bentata, P. Honore, Xuan Tuyet, J.F. Delfraissy, F. Chaix, M.T. Rannou, Y. Levy, A. Sobel, C. Dumont, S. Abel, S. Pierre-François, V. Beaujolais, I. Poizot-Martin, O. Zaegel-Faucher, C. Debreux, J. Moreau, E. Van Der Gheynst, M.C. Thiebaut-Drobacheff, A. Foltzer, B. Hoen, J.F. Faucher, H. Gil, J.M. Ragnaud, I. Raymond, I. Louis, M. Hessamfar, V. Baillat, C Merle De Boever, C. Tramoni, A. Soufflet, P. Guadagnin, P. Choutet, O. Mounoury, D. Brosseau, H. Hue, T. May, S. Wassoumbou, M. Stenzel, M.P. Bouillon, Y. Yazdanpanah, T. Huleux, E. Aissi, S. Pavel, D. Rey, P. Fischer, G. Blaison, M. Martinot, A. Pachart, F. Jeanblanc, J.L. Touraine, C. Trepo, P. Miailhes, K. Kouadjo, V. Thoirain, C. Brochier, P. Perre, S. Leautez, J.L. Esnault, and I. Suaud
- Subjects
Perinatal HIV infection ,Cohort ,Viral failure ,Immunological outcome ,Epidemiology ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: No study has compared the virological and immunological status of young people with perinatally-acquired HIV infection (P-HIV) with that of people with HIV adulthood (A-HIV) having a similar duration of infection. Methods: 5 French cohorts of P-HIV and A-HIV patients with a known date of HIV-infection and receiving antiretroviral treatment (ART), were used to compare the following proportions of: virological failure (VF) defined as plasma HIV RNA ≥ 50 copies/mL, CD4 cell percentages and CD4:CD8 ratios, at the time of the most recent visit since 2012. The analysis was stratified on time since infection, and multivariate models were adjusted for demographics and treatment history. Findings: 310 P-HIV were compared to 1515 A-HIV (median current ages 20.9 [IQR:14.4–25.5] and 45.9 [IQR:37.9–53.5] respectively). VF at the time of the most recent evaluation was significantly higher among P-HIV (22.6%, 69/306) than A-HIV (3.3%, 50/1514); p ≤ 0.0001. The risk of VF was particularly high among the youngest children (2–5 years), adolescents (13–17 years) and young adults (18–24 years), compared to A-HIV with a similar duration of infection: adjusted Odds-Ratio (aOR) 7.0 [95% CI: 1.7; 30.0], 11.4 [4.2; 31.2] and 3.3 [1.0; 10.8] respectively. The level of CD4 cell percentages did not differ between P-HIV and A-HIV. P-HIV aged 6–12 and 13–17 were more likely than A-HIV to have a CD4:CD8 ratio ≥ 1: 84.1% vs. 58.8% (aOR = 3.5 [1.5; 8.3]), and 60.9% vs. 54.7% (aOR = 1.9 [0.9; 4.2]) respectively. Interpretation: P-HIV were at a higher risk of VF than A-HIV with a similar duration of infection, even after adjusting for treatment history, whereas they were not at a higher risk of immunological impairment. Exposure to viral replication among young patients living with HIV since birth or a very early age, probably because of lower adherence, could have an impact on health, raising major concerns about the selection of resistance mutations and the risk of HIV transmission. Funding: Inserm - ANRS MIE.
- Published
- 2024
- Full Text
- View/download PDF
3. Physical activity for obstructive sleep apnea after stroke? A pilot study assessing the contribution of body fluids
- Author
-
Frange, Cristina, Elias, Rosilene Motta, Siengsukon, Catherine, and Coelho, Fernando Morgadinho Santos
- Published
- 2023
- Full Text
- View/download PDF
4. Infecciones fúngicas en pediatría
- Author
-
Frange, P., Blaizot, R., Garraffo, A., Poey, N., Benderdouche, M., Ovetchkine, P., Toubiana, J., and Angoulvant, A.
- Published
- 2023
- Full Text
- View/download PDF
5. Trainee Perspectives Regarding Advanced Clinical Global Health Fellowships in North America.
- Author
-
Frange, Adam, Duffy, Sean, Al-Rousan, Tala, Evensen, Ann, and Nelson, Brett D
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Clinical Sciences ,Health Sciences ,Adult ,Career Choice ,Education ,Medical ,Fellowships and Scholarships ,Female ,Global Health ,Humans ,Internship and Residency ,Male ,Middle Aged ,North America ,Physicians ,Surveys and Questionnaires ,Medical and Health Sciences ,Tropical Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
Postgraduate clinical global health (GH) training is a rapidly evolving field. To understand and improve training opportunities, we sought the perspectives of current and former trainees related to their advanced clinical training or global health fellowships and the anticipated impact on their careers. Clinical GH fellowships across North America were identified through websites and previous studies. An e-mail was sent to program directors to invite all current and former GH fellows to complete a web-based questionnaire. We contacted 100 GH fellowship programs. Fifty-two fellows from 10 different specialties completed the survey. The median fellowship length was 23.3 months, with an annual median of 4.8 months spent in low-income and middle-income countries, which was less than their reported ideal of 6 months. The majority reported satisfaction, the anticipation of career benefits, and that they would recommend fellowship training to others. Challenges included insufficient funding, mentorship, and formal curricula. Conducting research in high-income countries was a significant negative predictor of fellowship satisfaction. Most fellows (73.1%) were not at all or only a little concerned about the absence of fellowship accreditation, with only 17.3% desiring accreditation. Survey respondents were largely satisfied with their training and valued program flexibility and educational opportunities, including advanced tropical medicine certificates or diplomas. However, to improve fellowship training, improvements are needed in mentorship, standardized curricula, institutional support, and funding. For GH fellowship training to be effective and sustainable, institutions will need to balance the needs of fellows, training programs, and the communities (low-, middle-, and high-income countries) where the fellows serve.
- Published
- 2021
6. Accident d’exposition virale – VIH
- Author
-
Haas, H., primary, Pinto-Cardoso, G., additional, Pinquier, D., additional, and Frange, P., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Prevalence and risk factors of toxigenic Clostridioides difficile asymptomatic carriage in 11 French hospitals
- Author
-
Sarah Jolivet, Jeanne Couturier, Patrick Grohs, Aurélie Vilfaillot, Jean-Ralph Zahar, Pierre Frange, Anne Casetta, Véronique Moulin, Christine Lawrence, Patricia Baune, Cléo Bourgeois, Axel Bouffier, Claudine Laussucq, Lydia Sienzonit, Simon Picard, Isabelle Podglajen, Najiby Kassis-Chikhani, and Frédéric Barbut
- Subjects
Clostridioides difficile ,colonization ,asymptomatic ,prevalence ,risk factors ,Medicine (General) ,R5-920 - Abstract
Clostridioides difficile infection (CDI) incidence has increased over the last 20 years. Studies suggest that asymptomatic carriers may be an important reservoir of C. difficile in healthcare settings. We conducted a point prevalence study to estimate the toxigenic C. difficile asymptomatic carriage rate and the associated risk factors in patients >3 years old. Between September 16, 2019 and January 15, 2020, all patients hospitalized in 11 healthcare facilities in the Paris urban area were included in the study. They were screened on the day of the survey for toxigenic C. difficile carriage by rectal swab and interviewed. Isolates were characterized by PCR ribotyping and multiplex PCR targeting toxin genes. A logistic regression model was used to determine the risk factors associated with toxigenic C. difficile asymptomatic carriage using uni- and multivariate analysis in the subpopulation of patients >3 years old. During the study period, 2,389 patients were included and screened. The median age was 62 years (interquartile range 35–78 years) and 1,153 were male (48.3%). Nineteen patients had a previous CDI (0.9%). Overall, 185/2389 patients were positive for C. difficile (7.7%), including 93 toxigenic strains (3.9%): 77 (82.8%) were asymptomatic (prevalence 3.2%) whereas 12 (12.9%) were diarrheic. Prevalences of toxigenic C. difficile were 3.5% in patients >3 years old and 7.0% in ≤3 years old subjects, respectively. Toxigenic strains mainly belonged to PCR ribotypes 106 (n = 14, 15.0%), 014 (n = 12, 12.9%), and 020 (n = 10, 10.8%). Among toxigenic strains, 6 (6.4%) produced the binary toxin. In multivariate analysis, two factors were positively associated with toxigenic C. difficile asymptomatic carriage in patients >3 years old: multidrug-resistant organisms co-carriage [adjusted Odd Ratio (aOR) 2.3, CI 95% 1.2–4.7, p = 0.02] and previous CDI (aOR 5.8, CI 95% 1.2–28.6, p = 0.03). Conversely, consumption of raw milk products were associated with reduced risk of toxigenic C. difficile colonization (aOR 0.5, CI 95% 0.2–0.9, p = 0.01). We showed that there was a low prevalence of asymptomatic toxigenic C. difficile carriage in hospitalized patients. Consumption of raw milk prevents toxigenic C. difficile colonization, probably due to the barrier effect of milk-associated bacteria.
- Published
- 2023
- Full Text
- View/download PDF
8. Practice recommendations for the role of physiotherapy in the management of sleep disorders: the 2022 Brazilian Sleep Association Guidelines
- Author
-
Cristina Frange, Aline Marques Franco, Evelyn Brasil, Raquel Pastrello Hirata, Juliana Arcanjo Lino, Daiana Moreira Mortari, Daisy Satomi Ykeda, Mario André Leocádio-Miguel, Carolina Vicaria Rodrigues D’Aurea, Luciana Oliveira e Silva, Susana Cristina Lerosa Telles, Sofia Fontanello Furlan, Bruno Búrigo Peruchi, Camila Ferreira Leite, Fabiana Tokie Yagihara, Leticia Dominguez Campos, Melissa Araújo Ulhôa, Moara Gomes da Rocha Cruz, Ricardo Beidacki, Ronaldo Batista Santos, Sandra Souza de Queiroz, Simone Barreto, Vivien Schmeling Piccin, Fernando Morgadinho Santos Coelho, Luciana Studart, Marcia Assis, and Luciano F. Drager
- Subjects
sleep ,sleep disorders ,physiotherapy ,rehabilitation ,sleep health. ,Psychology ,BF1-990 ,Consciousness. Cognition ,BF309-499 - Abstract
This clinical guideline supported by the Brazilian Sleep Association comprises a brief history of the development of Brazilian sleep physiotherapy, outlines the role of the physiotherapist as part of a sleep health team, and describes the clinical guidelines in respect of the management of some sleep disorders by the physiotherapist (including sleep breathing disorders, i.e., obstructive sleep apnea, central sleep apnea, upper airway resistance syndrome, hypoventilation syndromes and overlap syndrome, and pediatric sleep breathing disorders; sleep bruxism; circadian rhythms disturbances; insomnia; and Willis-Ekbom disease/periodic limb movement disorder. This clinical practice guideline reflects the state of the art at the time of publication and will be reviewed and updated as new information becomes available.
- Published
- 2022
- Full Text
- View/download PDF
9. COVID-19 and Central Nervous System Hypersomnias
- Author
-
Frange, Cristina, de Oliveira, Giuliano Paz, and Coelho, Fernando Morgadinho Santos
- Published
- 2022
- Full Text
- View/download PDF
10. Setting up of a hospital Covid‐19 vaccination center: A descriptive study
- Author
-
Scarlett Wise, Fanny Lanternier, Camille Cotteret, Céline Chasport, Virginie Juin‐Leonard, Amélie Cantat, Anne Scemla, Claire Delage, Barbara Mantz, Caroline Telion, Pierre Carli, Pierre Frange, and Salvatore Cisternino
- Subjects
Covid‐19 pandemic ,hospital vaccination campaign ,management ,multidisciplinary cooperation ,organization ,public health ,Medicine - Abstract
Abstract Background and Aims The coronavirus pandemic challenged countries worldwide in a race against contaminations and variants. Vaccination campaigns were the answer to such an infectious spread. This descriptive study presents the organizational process of the setting up of a Covid‐19 vaccination center in a French University Hospital in January 2021, the issues encountered along the way and assessment of adaptability. Methods Three major stakeholders: SARS CoV‐2 crisis referent, referring vaccination medical doctor and referring vaccination pharmacist retraced key moments and identified issues encountered during the setting up of the vaccination center and its long term maintenance, threw a series of meetings. Records of crisis and periodic meetings that took place threw out the vaccination campaign were consulted. Results A multidisciplinary crisis steering committee with nine different professionals was created January 3. Logistics for the vaccination center opening were discussed: location, informatics, appointment‐scheduling, pharmaceutical circuit, internal circuit, human resources, and information communication. The vaccination center was ready to welcome healthcare workers in less than 24 h on January 4. The first month, 2757 1st shots were administered, leading up to a total of 9167 1st shots during 6 months of activity. From January to June 2021, the multidisciplinary group dealt and adapted its processes to challenging and unexpected situations. Indeed, issues encountered with Pfizer BioNTech's and AstraZeneca's vaccine, were: supply shortages, vaccine manipulation, targeted populations, pharmacovigilance, and general communication. Conclusion This descriptive study provides an exclusive insight on how a hospital vaccination center was organized and adapted during Covid‐19 pandemic to ensure healthcare workers' security and resilience, and to protect high risk patients of severe Covid‐19 infection.
- Published
- 2023
- Full Text
- View/download PDF
11. The association between sleep disturbances and tooth loss among post-stroke patients
- Author
-
Eliana Lottenberg VAGO, Cristina FRANGE, Giuliano DA PAZ OLIVEIRA, Maria Ligia JULIANO, Marco Antônio MACHADO, and Fernando Morgadinho Santos COELHO
- Subjects
Stroke ,Sleep ,Sleep Apnea, Obstructive ,Jaw, Edentulous ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
ABSTRACT Background: Loss of teeth has been associated with neurological and sleep disorders. It is considered to be a predictor of stroke and leads to modifications of airway patency and predisposition to obstructive sleep apnea. Objective: To investigate sleep quality, risk of obstructive sleep apnea and excessive sleepiness among post-stroke patients with tooth loss attending the Neurovascular Clinic of the Federal University of São Paulo. Methods: The prevalence rates of different types of stroke were assessed among 130 patients with different degrees of tooth loss, along with the presence of sleep disturbances, risk of obstructive sleep apnea and excessive daytime sleepiness. Results: The prevalence of ischemic stroke was 94.6%, with either no significant disability or slight disability. Our sample had poor sleep quality, and a high risk of obstructive sleep apnea, but without excessive daytime sleepiness. Half of our sample had lost between 9 and 31 teeth, and more than 25% had edentulism. The majority used full removable dental prostheses, and more than half of these individuals slept without removing the prosthesis. Conclusions: We found high prevalence of poor sleep quality and high risk of obstructive sleep apnea among post-stroke patients with tooth loss. This indicates the need for further studies on treating and preventing sleep disturbances in stroke patients with tooth loss.
- Published
- 2022
- Full Text
- View/download PDF
12. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France
- Author
-
Fourgeaud, Jacques, Toubiana, Julie, Chappuy, Hélène, Delacourt, Christophe, Moulin, Florence, Parize, Perrine, Scemla, Anne, Abid, Hanene, Leruez-Ville, Marianne, and Frange, Pierre
- Published
- 2021
- Full Text
- View/download PDF
13. Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies
- Author
-
Chaillon, Antoine, Essat, Asma, Frange, Pierre, Smith, Davey M, Delaugerre, Constance, Barin, Francis, Ghosn, Jade, Pialoux, Gilles, Robineau, Olivier, Rouzioux, Christine, Goujard, Cécile, Meyer, Laurence, Chaix, Marie-Laure, and on behalf the ANRS PRIMO Cohort Study
- Subjects
Microbiology ,Biological Sciences ,Clinical Research ,Genetics ,Infectious Diseases ,Sexually Transmitted Infections ,Sexual and Gender Minorities (SGM/LGBT*) ,HIV/AIDS ,Prevention ,2.2 Factors relating to the physical environment ,Infection ,Adolescent ,Adult ,Aged ,Cluster Analysis ,Female ,France ,Genotype ,HIV Infections ,HIV-1 ,Humans ,Male ,Middle Aged ,Molecular Epidemiology ,Sequence Analysis ,DNA ,Spatio-Temporal Analysis ,Young Adult ,pol Gene Products ,Human Immunodeficiency Virus ,Transmission network ,Phylogeography ,Primary infection ,Treatment as prevention ,on behalf the ANRS PRIMO Cohort Study ,Clinical Sciences ,Virology - Abstract
BackgroundCharacterizing HIV-1 transmission networks can be important in understanding the evolutionary patterns and geospatial spread of the epidemic. We reconstructed the broad molecular epidemiology of HIV from individuals with primary HIV-1 infection (PHI) enrolled in France in the ANRS PRIMO C06 cohort over 15 years.ResultsSociodemographic, geographic, clinical, biological and pol sequence data from 1356 patients were collected between 1999 and 2014. Network analysis was performed to infer genetic relationships, i.e. clusters of transmission, between HIV-1 sequences. Bayesian coalescent-based methods were used to examine the temporal and spatial dynamics of identified clusters from different regions in France. We also evaluated the use of network information to target prevention efforts. Participants were mostly Caucasian (85.9%) and men (86.7%) who reported sex with men (MSM, 71.4%). Overall, 387 individuals (28.5%) were involved in clusters: 156 patients (11.5%) in 78 dyads and 231 participants (17%) in 42 larger clusters (median size: 4, range 3-41). Compared to individuals with single PHI (n = 969), those in clusters were more frequently men (95.9 vs 83%, p
- Published
- 2017
14. Physical exercise as a therapeutic approach for adults with insomnia: systematic review and meta-analysis
- Author
-
Carolina Vicaria Rodrigues D’Aurea, Cristina Frange, Dalva Poyares, Altay Alves Lino de Souza, and Mario Lenza
- Subjects
Sleep ,Sleep initiation and maintenance disorders ,Yoga ,Tai Ji ,Exercise ,Exercise movement techniques ,Medicine - Abstract
ABSTRACT Objective To systematically review the effects (benefits and harms) of different types of physical exercise on insomnia outcomes in adult populations with no mood disorders. Objective and subjective sleep outcomes and related mismatches were analyzed. Methods Systematic review and meta-analysis. Quality of evidence was also examined. Results Six studies including 295 participants with insomnia diagnosis were selected. Yoga, Tai Chi, resistance exercise and aerobic exercise were used in protocols with different duration, intensity and frequency. Studies involved different populations, including inactive or sedentary individuals, older adults and postmenopausal women. Physical exercise improved subjective sleep quality (very low quality of evidence) and reduced insomnia severity (high quality of evidence). Conclusion Findings suggest individualized physical exercise must be addressed to design optimal protocols, with standardized type, duration, intensity, and frequency. For the time being, physical exercise may be considered an alternative and/or ancillary therapeutic modality for patients diagnosed with insomnia. Physical exercise can be used to improve subjective complaints, but not objective sleep outcomes.
- Published
- 2022
- Full Text
- View/download PDF
15. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study
- Author
-
Poline, Julie, Postaire, Martine, Parize, Perrine, Pilmis, Benoit, Bille, Emmanuelle, Zahar, Jean Ralph, Frange, Pierre, Cohen, Jérémie F., Lortholary, Olivier, and Toubiana, Julie
- Published
- 2021
- Full Text
- View/download PDF
16. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)
- Author
-
Schnell, David, Azoulay, Elie, Benoit, Dominique, Clouzeau, Benjamin, Demaret, Pierre, Ducassou, Stéphane, Frange, Pierre, Lafaurie, Matthieu, Legrand, Matthieu, Meert, Anne-Pascale, Mokart, Djamel, Naudin, Jérôme, Pene, Frédéric, Rabbat, Antoine, Raffoux, Emmanuel, Ribaud, Patricia, Richard, Jean-Christophe, Vincent, François, Zahar, Jean-Ralph, and Darmon, Michael
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Hematology ,Rare Diseases ,Good Health and Well Being ,Antibiotics ,Guidelines ,Intensive care units ,Isolation ,Neutropenia ,Prognosis ,Public Health and Health Services ,Clinical sciences - Abstract
Neutropenia is defined by either an absolute or functional defect (acute myeloid leukemia or myelodysplastic syndrome) of polymorphonuclear neutrophils and is associated with high risk of specific complications that may require intensive care unit (ICU) admission. Specificities in the management of critically ill neutropenic patients prompted the establishment of guidelines dedicated to intensivists. These recommendations were drawn up by a panel of experts brought together by the French Intensive Care Society in collaboration with the French Group for Pediatric Intensive Care Emergencies, the French Society of Anesthesia and Intensive Care, the French Society of Hematology, the French Society for Hospital Hygiene, and the French Infectious Diseases Society. Literature review and formulation of recommendations were performed using the Grading of Recommendations Assessment, Development and Evaluation system. Each recommendation was then evaluated and rated by each expert using a methodology derived from the RAND/UCLA Appropriateness Method. Six fields are covered by the provided recommendations: (1) ICU admission and prognosis, (2) protective isolation and prophylaxis, (3) management of acute respiratory failure, (4) organ failure and organ support, (5) antibiotic management and source control, and (6) hematological management. Most of the provided recommendations are obtained from low levels of evidence, however, suggesting a need for additional studies. Seven recommendations were, however, associated with high level of evidences and are related to protective isolation, diagnostic workup of acute respiratory failure, medical management, and timing surgery in patients with typhlitis.
- Published
- 2016
17. Development and validation of the sleep assessment instrument for older adults with pain
- Author
-
Márcia Valéria de Andrade Santana, Ricardo Humberto Félix, Ana Laura de Figueiredo Bersani, Cristina Frange, Fernando Morgadinho Santos Coelho, Osvladir Custódio, and Fania Cristina Santos
- Subjects
Sleep ,Pain ,Aged ,Surveys and Questionnaires ,Health Impact Assessment ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Background: The co-occurrence of chronic pain and sleep disturbance contribute to a significant functional and social impact in older adults. However, there are no validated instruments to measure sleep disturbance and pain in this population that could be used to screen or diagnose individuals or monitor treatment effectiveness. Objective: Our aim was to develop and validate a brief, practical, and comprehensive tool to assess the impact of co-occurring pain and sleep disturbance in older adults. Methods: Development and validation of a measurement tool for assessing pain and sleep in older adults consisting of seven items. Results: We applied the “Sleep Assessment Instrument for Pain in older adults” (SAIOAP) in a sample of 100 older individuals. A Cronbach’s alpha of 0.602 indicated a moderate level of reliability, and item-total correlations of ≥0.4 for all items indicated good homogeneity. There were statistically significant correlations between the SAIOAP and sleep quality (PSQI, r=61.5), pain intensity (VNS, r=30.5), the multidimensional impacts of pain (GPM, r=40.5), depression (GEAP, r=45.5), comorbidity (r=27.9), and medication use (r=30.4). A ROC curve indicated a sensitivity of 73.2% and a specificity of 79.1% in relation to the prediction of sleep disturbances associated with pain in older adults. Conclusions: The SAIOAP presented adequate metric properties and was demonstrated to be a simple and practical tool for the assessment of the impact of pain on sleep in older adults.
- Published
- 2021
- Full Text
- View/download PDF
18. Helicobacter pylori eradication in renal transplant candidates
- Author
-
Mariana E. Maioli, Raquel F. N. Frange, Cintia M. C. Grion, and Vinicius D. A. Delfino
- Subjects
Renal Insufficiency, Chronic ,Helicobacter pylori ,Kidney Transplantation ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Introduction: Treatment for Helicobacter pylori (H. pylori) infection is recommended in transplant candidates due to the association between this infection and gastrointestinal disorders, which could significantly increase morbidity after renal transplantation with the use of immunosuppression. The objective of this study was to analyze the rate of eradication of H. pylori after antimicrobial treatment in chronic kidney disease patients who are candidates for kidney transplantation. Methods: A multicenter prospective cohort study was conducted. All adult chronic kidney disease patients seen at our institution were included. In the pre-transplantation evaluation, 83 patients underwent an upper gastrointestinal endoscopy with 2 diagnostic methods to detect H. pylori: histology and the rapid urease test. In total, 33 patients with H. pylori infection received treatment with 20 mg omeprazole, 500 mg amoxicillin, and 500 mg clarithromycin once daily for 14 days. Another upper gastrointestinal endoscopy was performed 8 to 12 weeks after the end of treatment to check for healing. Results: The study showed a prevalence of H. pylori in 51 (61.4%) patients. Histology was positive in 50 (98%) patients and the rapid urease test was positive in 31 (60.8%). The infection eradication rate was 48.5% (16 patients). Conclusions: There was a high prevalence rate of H. pylori and a low eradication rate after the long-term antimicrobial triple scheme used. The association of the rapid urease test with gastric mucosa histology did not increase the detection rate of H. pylori.
- Published
- 2022
- Full Text
- View/download PDF
19. Severe and fatal forms of COVID-19 in children
- Author
-
Oualha, M., Bendavid, M., Berteloot, L., Corsia, A., Lesage, F., Vedrenne, M., Salvador, E., Grimaud, M., Chareyre, J., de Marcellus, C., Dupic, L., de Saint Blanquat, L., Heilbronner, C., Drummond, D., Castelle, M., Berthaud, R., Angoulvant, F., Toubiana, J., Pinhas, Y., Frange, P., Chéron, G., Fourgeaud, J., Moulin, F., and Renolleau, S.
- Published
- 2020
- Full Text
- View/download PDF
20. High rates of antiretroviral coverage and virological suppression in HIV-1-infected children and adolescents
- Author
-
Soumah, A., Avettand-Fenoel, V., Veber, F., Moshous, D., Mahlaoui, N., Blanche, S., and Frange, P.
- Published
- 2020
- Full Text
- View/download PDF
21. EPH176 Comorbidities Among Individuals at Risk to Develop Severe Form of COVID-19 in Case of Sars-Cov-2 Infection
- Author
-
Guyot, E., primary, Béraud, G., additional, Ausset-Moraillon, A., additional, Belhassen, M., additional, Jacoud, F., additional, Mackosso, C., additional, Solas Chesneau, C., additional, and Frange, P., additional
- Published
- 2023
- Full Text
- View/download PDF
22. Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)
- Author
-
Frange, P., primary, Veber, F., additional, Burgard, M., additional, Blanche, S., additional, and Avettand‐Fenoel, V., additional
- Published
- 2023
- Full Text
- View/download PDF
23. Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units
- Author
-
Decalonne, Marie, Dos Santos, Sandra, Gimenes, Rémi, Goube, Florent, Abadie, Géraldine, Aberrane, Saïd, Ambrogi, Vanina, Baron, Raoul, Barthelemy, Patrick, Bauvin, Isabelle, Belmonte, Olivier, Benabid, Emilie, Ammar, Rafik Ben, Yahia, Salma Ben Hadj, Berrouane, Yasmina, Berthelot, Philippe, Beuchee, Alain, Bille, Emmanuelle, Bolot, Pascal, Bordes-Couecou, Stéphanie, Bouissou, Antoine, Bourdon, Sandra, Bourgeois-Nicolaos, Nadège, Boyer, Sophie, Cattoen, Christian, Cattoir, Vincent, Chaplain, Chantal, Chatelet, Céline, Claudinon, Aurore, Chautemps, Nathalie, Cormier, Hélène, Coroller-Bec, Céline, Cotte, Benjamin, De Chillaz, Carole, Dauwalder, Olivier, Davy, Aude, Delorme, Martine, Demasure, Maryvonne, Desfrere, Luc, Drancourt, Michel, Dupin, Clarisse, Faraut-Derouin, Véronique, Florentin, Arnaud, Forget, Virginie, Fortineau, Nicolas, Foucan, Tania, Frange, Pierre, Gambarotto, Karine, Gascoin, Géraldine, Gibert, Laure, Gilquin, Jacques, Glanard, Audrey, Grando, Jacqueline, Gravet, Alain, Guinard, Jérôme, Hery-Arnaud, Geneviève, Huart, Claire, Idri, Nadia, Jellimann, Jean-Marc, Join-Lambert, Olivier, Joron, Sylvie, Jouvencel, Philippe, Kempf, Marie, Ketterer-Martinon, Sophie, Khecharem, Mouna, Klosowski, Serge, Labbe, Franck, Lacazette, Adeline, Lapeyre, Fabrice, Larche, Jérôme, Larroude, Peggy, Le Pourhiennec, Anne, Le Sache, Nolwenn, Ledru, Sylvie, Lefebvre, Annick, Legeay, Clément, Lemann, Florence, Lesteven, Claire, Levast-Raffin, Marion, Leyssene, David, Ligi, Isabelle, Lozniewski, Alain, Lureau, Pierre, Mallaval, Franck-Olivier, Malpote, Edith, Marret, Stéphane, Martres, Pascale, Menard, Guillaume, Menvielle, Laura, Mereghetti, Laurent, Merle, Véronique, Minery, Pascale, Morange, Virginie, Mourdie, Julien, Muggeo, Anaelle, Nakhleh, Jean, Noulard, Marie-Noëlle, Olive, Claude, Patural, Hugues, Penn, Pascale, Petitfrere, Manuel, Pozetto, Bruno, Riviere, Brigitte, Robine, Audrey, Ceschin, Christine Roques, Ruimy, Raymond, Siali, Amine, Soive, Stéphanie, Slimani, Souad, Trentesaux, Anne-Sophie, Trivier, Dominique, Vandenbussche, Christian, Villeneuve, Laurent, Werner, Evelyne, Le Vu, Stéphane, and Van Der Mee-Marquet, Nathalie
- Published
- 2020
- Full Text
- View/download PDF
24. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies
- Author
-
Frange, Pierre, Assoumou, Lambert, Descamps, Diane, Chéret, Antoine, Goujard, Cécile, Tran, Laurent, Gousset, Marine, Avettand-Fenoël, Veronique, Bocket, Laurence, Fafi-Kremer, Samira, Guinard, Jerome, Morand-Joubert, Laurence, Nicot, Florence, Plantier, Jean-Christophe, Rogez, Sylvie, Wirden, Marc, Rouzioux, Christine, Meyer, Laurence, Chaix, Marie-Laure, Abel, S, Abraham, B, Allegre, T, Antoniotti, A, Armero, R, Audhuy, B, Aumaitre, H, Beaucaire, G, Beck-Wirth, G, Berger, JL, Bernard, L, Beuscart, C, Bodard, L, Bouchaud, O, Boué, F, Cabane, J-P, Cabie, A, Champagne, H, Cheneau, C, Chennebault, J-M, Cheret, A, Christian, B, Compagnucci, A, Daneluzzi, V, Debab, Y, Dellamonica, P, Delfraissy, J-F, Devidas, A, Diab, G, Doll, J, Drobacheff-Thebaut, MC, Durel, A, Duvivier, C, Esnault, J-L, Faba, L, Froguel, E, Garipuy, D, Garrait, V, Geffray, L, Genet, C, Genet, P, Gerard, L, Ghosn, J, Girard, J-J, Girard, P-M, Godin-Collet, C, Hochedez, P, Hoen, B, Houlbert, D, Jacomet, C, Jeantils, V, Jidar, K, Katlama, C, Klement, E, Lafeuillade, A, Lascoux, C, Launay, V, Lepretre, A, Levy, Y, Makhloufi, D, Malbec, D, Martha, B, May, T, Merrien, D, Miailhes, P, Miodovski, C, Molina, J-M, Morlat, P, Mortier, E, Neau, D, Obadia, M, Patey, O, Pellegrin, J-L, Perronne, V, Philibert, P, Pialoux, G, Pichancourt, G, Piroth, L, Poinsignon, Y, Poizot-Martin, I, and Prazuck, T
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,HIV/AIDS ,Antimicrobial Resistance ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Infection ,Anti-HIV Agents ,Disease Transmission ,Infectious ,Drug Resistance ,Viral ,Female ,France ,Genotype ,Genotyping Techniques ,HIV Infections ,HIV-1 ,Homosexuality ,Male ,Humans ,Male ,Mutation ,Missense ,Prevalence ,resistance-associated mutations ,primary HIV infection ,French ANRS CO 6 PRIMO Cohort ,the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups ,French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups ,Microbiology ,Pharmacology and Pharmaceutical Sciences ,Clinical sciences ,Pharmacology and pharmaceutical sciences - Abstract
BackgroundOur study describes the prevalence of transmitted drug resistance (TDR) among 1318 French patients diagnosed at the time of primary HIV-1 infection (PHI) in 2007-12.MethodsHIV-1 resistance-associated mutations (RAMs) were characterized using both the 2009 WHO list of mutations and the French ANRS algorithm. A genotypic susceptibility score was estimated for each first-line recommended ART combination.ResultsPatients were mainly MSM (72.6%). Non-B variants were identified in 33.7% of patients. The proportion of TDR was estimated as 11.7% (95% CI 10.0-13.5). The prevalences of PI-, NRTI-, first-generation NNRTI and etravirine/rilpivirine-associated RAMs were 2.5%, 5.2%, 3.9% and 3.2%, respectively. Single, dual and triple class resistance was found in 9.6%, 1.0% and 1.1% of cases, respectively. Additionally, 5/331 strains isolated in 2010-12 had integrase inhibitor (II)-related RAMs (isolated E157Q mutation in all cases). TDR was more common among MSM than in other groups (12.9% versus 8.6%, P = 0.034), and in case of B versus non-B subtype infections (13.6% versus 7.9%, P = 0.002). The proportions of fully active combinations were ≥99.2%, ≥97.3% and ≥95.3% in cases of PI-, II- and NNRTI-based regimens, respectively. In 2010-12, the proportion of fully active efavirenz-based ART was lower in cases of subtype B versus non-B infection (P = 0.021).ConclusionsCompared with our previous studies, the proportion of NRTI- and first-generation NNRTI-related TDR has continued to decline in French seroconverters. However, subtype B-infected MSM could drive the spread of resistant HIV strains. Finally, we suggest preferring PI- or II- to NNRTI-based combinations to treat PHI patients.
- Published
- 2015
25. 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada
- Author
-
Pate, Kelly Metcalf, Pohlmeyer, Chris, Walker‐Sperling, Victoria, Foote, Jeremy, Najarro, Kevin, Cryer, Catherine, Salgado, Maria, Gama, Lucio, Engle, Elizabeth, Shirk, Erin, Queen, Suzanne, Chioma, Stanley, Vermillion, Meghan, Bullock, Brandon, Li, Ming, Lyons, Claire, Adams, Robert, Zink, Chris, Clements, Janice, Mankowski, Joseph, Blankson, Joel, Micci, Luca, Ryan, Emily, Fromentin, Rémi, Benne, Clarisse, Chomont, Nicolas, Lifson, Jeffrey, Paiardini, Mirko, Lee, Sulggi, Fromentin, Remi, Silicano, Robert, Silicano, Janet, Richman, Douglas, O'Doherty, Una, Palmer, Sarah, Burbelo, Peter, Deeks, Steven, Ghneim, Khader, Ahlers, Jeff, Fourati, Slim, Shive, Carey, Cameron, Mark, Mukerjee, Pranab, Ghannoum, Mahmoud, Rodriguez, Benigno, Lederman, Michael, Sekaly, Rafick, Frange, Pierre, Faye, Albert, Avettand‐Fenoel, Veronique, Bellaton, Erainna, Deschamps, Diane, Angin, Mathieu, Caillat‐Zucman, Sophie, Peytavin, Gilles, Le Chenadec, Jerome, Warszawski, Josiane, Rouzioux, Christine, Saez‐Cirion, Asier, Cohort, ANRS Epf‐Co10 Pediatric, Chang, Christina, Cameron, Paul, Elliott, Julian, Perelson, Alan, Roche, Michael, Dantanarayana, Ashanti, Solomon, Ajantha, Naranbhai, Vivek, Tenakoon, Surekha, Hoh, Rebecca, McMahon, James, Sikaris, Ken, Hartogensis, Wendy, Bacchetti, Peter, Hecht, Frederick, Deeks, Steve, Lewin, Sharon, Byrareddy, Siddappa, Arthos, James, Cicala, Claudia, Reimann, Keith, Parslow, Tristram, Santangelo, Philip, Villinger, Francois, Fauci, Anthony, Ansari, Aftab, George, Michael, Weiser, Barbara, Burger, Harold, Lewy, Tyler, Anastos, Kathryn, Asmuth, David, Somsouk, Ma, Hunt, Peter, Min, Zhong, Miller, Christopher, and Li, Xiao Dong
- Subjects
Mental Health ,Digestive Diseases ,Infectious Diseases ,Pediatric AIDS ,Bioengineering ,Prevention ,Clinical Research ,Genetics ,Health Services ,Pediatric ,Behavioral and Social Science ,HIV/AIDS ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Infection ,Reproductive health and childbirth ,Good Health and Well Being ,Clinical Sciences ,Public Health and Health Services ,Other Medical and Health Sciences - Published
- 2015
26. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
- Author
-
Rhee, Soo-Yon, Blanco, Jose Luis, Jordan, Michael R, Taylor, Jonathan, Lemey, Philippe, Varghese, Vici, Hamers, Raph L, Bertagnolio, Silvia, de Wit, Tobias F Rinke, Aghokeng, Avelin F, Albert, Jan, Avi, Radko, Avila-Rios, Santiago, Bessong, Pascal O, Brooks, James I, Boucher, Charles AB, Brumme, Zabrina L, Busch, Michael P, Bussmann, Hermann, Chaix, Marie-Laure, Chin, Bum Sik, D'Aquin, Toni T, De Gascun, Cillian F, Derache, Anne, Descamps, Diane, Deshpande, Alaka K, Djoko, Cyrille F, Eshleman, Susan H, Fleury, Herve, Frange, Pierre, Fujisaki, Seiichiro, Harrigan, P Richard, Hattori, Junko, Holguin, Africa, Hunt, Gillian M, Ichimura, Hiroshi, Kaleebu, Pontiano, Katzenstein, David, Kiertiburanakul, Sasisopin, Kim, Jerome H, Kim, Sung Soon, Li, Yanpeng, Lutsar, Irja, Morris, Lynn, Ndembi, Nicaise, Kee, Peng NG, Paranjape, Ramesh S, Peeters, Martine, Poljak, Mario, Price, Matt A, Ragonnet-Cronin, Manon L, Reyes-Terán, Gustavo, Rolland, Morgane, Sirivichayakul, Sunee, Smith, Davey M, Soares, Marcelo A, Soriano, Vincent V, Ssemwanga, Deogratius, Stanojevic, Maja, Stefani, Mariane A, Sugiura, Wataru, Sungkanuparph, Somnuek, Tanuri, Amilcar, Tee, Kok Keng, Truong, Hong-Ha M, van de Vijver, David AMC, Vidal, Nicole, Yang, Chunfu, Yang, Rongge, Yebra, Gonzalo, Ioannidis, John PA, Vandamme, Anne-Mieke, and Shafer, Robert W
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Good Health and Well Being ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Published
- 2015
27. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
- Author
-
Pate, Kelly Metcalf, Pohlmeyer, Chris, Walker-Sperling, Victoria, Foote, Jeremy, Najarro, Kevin, Cryer, Catherine, Salgado, Maria, Gama, Lucio, Engle, Elizabeth, Shirk, Erin, Queen, Suzanne, Chioma, Stanley, Vermillion, Meghan, Bullock, Brandon, Li, Ming, Lyons, Claire, Adams, Robert, Zink, Chris, Clements, Janice, Mankowski, Joseph, Blankson, Joel, Micci, Luca, Ryan, Emily, Fromentin, Rémi, Benne, Clarisse, Chomont, Nicolas, Lifson, Jeffrey, Paiardini, Mirko, Lee, Sulggi, Fromentin, Remi, Silicano, Robert, Silicano, Janet, Richman, Douglas, O'Doherty, Una, Palmer, Sarah, Burbelo, Peter, Deeks, Steven, Ghneim, Khader, Ahlers, Jeff, Fourati, Slim, Shive, Carey, Cameron, Mark, Mukerjee, Pranab, Ghannoum, Mahmoud, Rodriguez, Benigno, Lederman, Michael, Sekaly, Rafick, Frange, Pierre, Faye, Albert, Avettand-Fenoel, Veronique, Bellaton, Erainna, Deschamps, Diane, Angin, Mathieu, Caillat-Zucman, Sophie, Peytavin, Gilles, Le Chenadec, Jerome, Warszawski, Josiane, Rouzioux, Christine, Saez-Cirion, Asier, Chang, Christina, Cameron, Paul, Elliott, Julian, Perelson, Alan, Roche, Michael, Dantanarayana, Ashanti, Solomon, Ajantha, Naranbhai, Vivek, Tenakoon, Surekha, Hoh, Rebecca, McMahon, James, Sikaris, Ken, Hartogensis, Wendy, Bacchetti, Peter, Hecht, Frederick, Deeks, Steve, Lewin, Sharon, Byrareddy, Siddappa, Arthos, James, Cicala, Claudia, Reimann, Keith, Parslow, Tristram, Santangelo, Philip, Villinger, Francois, Fauci, Anthony, Ansari, Aftab, George, Michael, Weiser, Barbara, Burger, Harold, Lewy, Tyler, Anastos, Kathryn, Asmuth, David, Somsouk, Ma, Hunt, Peter, Min, Zhong, Miller, Christopher, Li, Xiao Dong, and Hinkle, John
- Subjects
Clinical Sciences ,Public Health and Health Services ,Other Medical and Health Sciences - Published
- 2015
28. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study
- Author
-
Pierre Frange, Thomas Montange, Jérôme Le Chenadec, Damien Batalie, Ingrid Fert, Catherine Dollfus, Albert Faye, Stéphane Blanche, Anne Chacé, Corine Fourcade, Isabelle Hau, Martine Levine, Nizar Mahlaoui, Valérie Marcou, Marie-Dominique Tabone, Florence Veber, Alexandre Hoctin, Thierry Wack, Véronique Avettand-Fenoël, Josiane Warszawski, and Florence Buseyne
- Subjects
HIV-1 ,children ,adolescents ,early ART ,T lymphocyte ,naive T lymphocyte ,Immunologic diseases. Allergy ,RC581-607 - Abstract
BackgroundThe early initiation of antiretroviral therapy (ART) in HIV-1-infected infants reduces mortality and prevents early CD4 T-cell loss. However, the impact of early ART on the immune system has not been thoroughly investigated in children over five years of age or adolescents. Here, we describe the levels of naive CD4 and CD8 T lymphocytes (CD4/CD8TN), reflecting the quality of immune reconstitution, as a function of the timing of ART initiation (early (
- Published
- 2021
- Full Text
- View/download PDF
29. Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections
- Author
-
Frange, P. and Leruez-Ville, M.
- Published
- 2018
- Full Text
- View/download PDF
30. Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023).
- Author
-
Frange, P., Veber, F., Burgard, M., Blanche, S., and Avettand‐Fenoel, V.
- Subjects
- *
HIV infections , *HIV integrase inhibitors , *GENETIC mutation , *VIRAL load , *TENOFOVIR , *PURINES , *DRUG resistance , *RETROSPECTIVE studies , *ACQUISITION of data , *TREATMENT failure , *RISK assessment , *GENOTYPES , *MEDICAL records , *DRUGS , *PATIENT compliance , *EMTRICITABINE , *FRENCH people , *NUCLEOSIDE reverse transcriptase inhibitors , *CHILDREN , *ADOLESCENCE - Abstract
Objectives: Although widely recommended, data on bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) efficacy in HIV‐1‐infected children/adolescents are mainly extrapolated from studies in adults and one paediatric trial in which subjects have good treatment adherence. This study aimed to provide data about the risk of virological failure (VF) and acquired genotypic resistance in children and adolescents receiving BIC/FTC/TAF in a real‐world setting. Methods: This retrospective monocentric study included 74 paediatric patients who received BIC/FTC/TAF during ≥6 months in 2019–2023. VF was defined as not achieving a plasma viral load <50 copies/mL within 6 months of BIC/FTC/TAF initiation or as experiencing virological rebound ≥50 copies/mL. Results: Most patients were antiretroviral therapy (ART)‐experienced (93.2%), previously exposed to integrase inhibitors (85.1%) and displayed viral suppression at baseline (67.6%). Their median age was 11.2 years [interquartile range (IQR): 8.8–15.2]. BIC/FTC/TAF introduction reduced treatment burden in most ART‐experienced subjects. Genotypic susceptibility score of BIC/FTC/TAF was ≥2 in all cases. Median follow‐up was 40 months (IQR: 21–46). VF occurred in 28 people (37.8%), more frequently in the case of VF versus viral suppression at baseline (68% vs. 26%, P = 0.02). BIC/FTC/TAF was interrupted for suspected intolerance in only one case (1.4%). Nucleoside reverse transcriptase inhibitor (NRTI) mutation (T69D/N) emerged in one patient (3.6% of VF) after 47 months of continuous detectable viraemia while on ART. No acquisition of mutations in the integrase gene was observed. Conclusion: Because of its high genetic barrier to resistance, BIC/FTC/TAF could be especially useful in the paediatric population, in which the risk of poor treatment adherence and VF is high. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
- Author
-
Ana C. Aguilar, Cristina Frange, Lucio H. Pimentel Filho, Maria J. Reis, Sergio Tufik, and Fernando M.S. Coelho
- Subjects
Sleep ,excessive daytime sleepiness ,weight gain ,obesity ,narcolepsy ,lisdexamfetamine ,Psychiatry ,RC435-571 - Abstract
Objective: To report the successful use of lisdexamfetamine in the management of narcolepsy. Methods: Five narcoleptic patients received lisdexamfetamine, at different dosages and for different periods, for management of excessive daytime sleepiness and weight control. Results: All patients experienced improvement of excessive daytime sleepiness and lost weight without side effects. Conclusion: Lisdexamfetamine appears promising for the treatment of two of the most common symptoms of narcolepsy: excessive daytime sleepiness and weight gain.
- Published
- 2019
- Full Text
- View/download PDF
32. Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
- Author
-
Marianne Delville, Fabien Touzot, Chloé Couzin, Isabelle Hmitou, Lounes Djerroudi, Amani Ouedrani, François Lefrère, Caroline Tuchman-Durand, Chloé Mollet, Jean-Roch Fabreguettes, Nicolas Ferry, Laurent Laganier, Alessandra Magnani, Elisa Magrin, Valérie Jolaine, Asier Saez-Cirion, Orit Wolstein, Geoffrey Symonds, Pierre Frange, Hélène Moins-Teisserenc, Marie-Laure Chaix-Baudier, Antoine Toubert, Jérôme Larghero, Nathalie Parquet, Anne C. Brignier, Françoise Barré-Sinoussi, Eric Oksenhendler, and Marina Cavazzana
- Subjects
Genetics ,QH426-470 ,Cytology ,QH573-671 - Abstract
Although the risk of developing lymphoma has decreased in the highly active antiretroviral therapy era, this cancer remains the major cause of mortality in HIV-infected patients. Autologous hematopoietic stem cell transplantation (ASCT) outcome does not differ for HIV-infected versus HIV-uninfected patients. We propose to develop a new treatment for HIV-associated high-risk lymphoma based on autologous transplantation of two genetically modified products: CD4+ T lymphocytes and CD34+ hematopoietic stem cells (HSPCs). The cells will be transduced ex vivo with the Cal-1 lentiviral vector encoding for both a short hairpin RNA (shRNA) against CCR5 (sh5) and the HIV-1 fusion inhibitor C46. The transduced cells will be resistant to HIV infection by two complementary mechanisms: impaired binding of the virus to the cellular CCR5 co-receptor and decreased fusion of the virus as C46 interacts with gp41 and inhibits HIV infection. This phase I/II pilot study, also entitled GENHIV, will involve two French participating centers: Saint Louis Hospital and Necker Hospital in Paris. We plan to enroll five HIV-1-infected patients presenting with high-risk lymphoma and require a treatment with ASCT. The primary objective of this study is to evaluate the safety, feasibility, and success of engraftment of Cal-1 gene-transduced CD4+ T lymphocytes and CD34+ HSPCs.
- Published
- 2019
- Full Text
- View/download PDF
33. Sleepiness comorbid to musculoskeletal pain is associated with worse quality of life and mood symptoms in a general population sample
- Author
-
Camila Hirotsu, Cristina Frange, Patricia H Hirata, Renata C Cremaschi, Fernando M Coelho, Monica L Andersen, and Sergio Tufik
- Subjects
sleep ,musculoskeletal pain ,disorders of excessive somnolence ,mood disorders ,quality of life ,Psychology ,BF1-990 ,Consciousness. Cognition ,BF309-499 - Abstract
Objectives: Musculoskeletal (MSK) pain and hypersomnolence (HPS) are very disabling conditions that may share some pathophysiological factors. This study aimed to evaluate the interaction between MSK pain and HPS and its association with mood symptoms, fatigue, quality of life, and both objective and subjective sleep quality. Design: Cross-sectional study. Setting: General population based sample. Participants: 510 individuals from EPISONO cohort, São Paulo (Brazil). Measurements: All participants completed questionnaires, had clinical assessment and underwent a full-night polysomnography. HPS was defined according to Epworth Sleepiness Scale while the presence of MSK pain was defined by structured questionnaire. The sample was allocated into 4 groups: control (CTRL, n=281), HPS (n=141), MSK (n=50), and both conditions (HPS+MSK, n=38). Results: MSK pain and HPS by themselves were associated with worse mood symptoms and quality of life. However, individuals with both associated conditions (HPS+MSK) presented higher frequencies of moderate to severe depression (44.1%) and anxiety symptoms (45.7%), as well as an additional decrease in quality of life compared to the other groups. There were no differences between HPS+MSK and MSK groups in objective sleep pattern. With regard to subjective sleep, HPS+MSK presented a higher prevalence of sleep attacks and cataplexy compared to all other groups. Conclusions: The combination of MSK pain and HPS was associated with worse mood symptoms, quality of life and HPS-related features. This study suggests that sleepiness may be an important symptom to be investigated and treated in MSK pain-related conditions for a better quality of life.
- Published
- 2019
- Full Text
- View/download PDF
34. Chlorine Solutions for a Safe Method of Decontamination of Breast Pump Milk Collection Kits Before and After the Coronavirus Disease 2019 Pandemic
- Author
-
Virginie Rigourd, Benali Mouadh, Joel Poupon, Jerome Langrand, Arnaud Goutard, Christine Droguet, Emmanuel Bille, Pierre Frange, Yasmina Bahri, David Pasquier, Alexandre Lapillonne, and David Skurnik
- Subjects
COVID-19 ,breastfeeding ,breast milk expression ,milk banks ,decontamination ,Nutrition. Foods and food supply ,TX341-641 - Abstract
To promote breast feeding and breast pumping is essential for the most vulnerable infants even if the current coronavirus disease 2019 (COVID-19) pandemic sanitary crisis imposes more stringent hygienic measures. As recommended by the Centers for Disease Control and Prevention, World Health Organization, and Milk Bank Association, “after each pumping session, all pump part that come into contact with breast milk should be appropriately disinfected.” The present study proposed different methods than can be used and focus on the safety analysis of chlorine solution (CS) in terms of residual hypochlorous acid (HCA) and total trihalomethanes (THM). We also performed an efficacy testing of the CS approach to decontaminate the devices used to collect the milk (breast pumps and bottles). The bacteriologic results of 1,982 breast pump milk samples collected in three different settings showed a major decrease of the microbial contamination using either sterile device or decontamination with CS compared to a simple soap washing. The main messages from our study are to propose a guideline for the safe use of CS and to define situations when breast pump decontamination might be necessary: vulnerable babies for which sterile device is recommended; special circumstances, for example the current COVID-19 pandemic; special situations, for example women living in precarious conditions; or women pumping their milk at work but that would have low or no access to boiled water. Overall, cold decontamination reduced losses of milk for bacteriological reasons in human milk banks and may also be interesting to prevent horizontal contamination by virus like COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
35. Infección del niño por el virus de la inmunodeficiencia humana de tipo 1
- Author
-
Frange, P. and Blanche, S.
- Published
- 2018
- Full Text
- View/download PDF
36. Ribosomal Protein SA Haploinsufficiency in Humans with Isolated Congenital Asplenia
- Author
-
Bolze, Alexandre, Mahlaoui, Nizar, Byun, Minji, Turner, Bridget, Trede, Nikolaus, Ellis, Steven R, Abhyankar, Avinash, Itan, Yuval, Patin, Etienne, Brebner, Samuel, Sackstein, Paul, Puel, Anne, Picard, Capucine, Abel, Laurent, Quintana-Murci, Lluis, Faust, Saul N, Williams, Anthony P, Baretto, Richard, Duddridge, Michael, Kini, Usha, Pollard, Andrew J, Gaud, Catherine, Frange, Pierre, Orbach, Daniel, Emile, Jean-Francois, Stephan, Jean-Louis, Sorensen, Ricardo, Plebani, Alessandro, Hammarstrom, Lennart, Conley, Mary Ellen, Selleri, Licia, and Casanova, Jean-Laurent
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Genetics ,Clinical Research ,Congenital Structural Anomalies ,Pediatric ,DNA Mutational Analysis ,Genetic Loci ,Haploinsufficiency ,Heterotaxy Syndrome ,Humans ,Mutation ,Pedigree ,Penetrance ,Receptors ,Laminin ,Ribosomal Proteins ,Spleen ,General Science & Technology - Abstract
Isolated congenital asplenia (ICA) is characterized by the absence of a spleen at birth in individuals with no other developmental defects. The patients are prone to life-threatening bacterial infections. The unbiased analysis of exomes revealed heterozygous mutations in RPSA in 18 patients from eight kindreds, corresponding to more than half the patients and over one-third of the kindreds studied. The clinical penetrance in these kindreds is complete. Expression studies indicated that the mutations carried by the patients-a nonsense mutation, a frameshift duplication, and five different missense mutations-cause autosomal dominant ICA by haploinsufficiency. RPSA encodes ribosomal protein SA, a component of the small subunit of the ribosome. This discovery establishes an essential role for RPSA in human spleen development.
- Published
- 2013
37. Preventing respiratory syncytial virus infections in hospitalized children and adults: should we do better?
- Author
-
Pierre Frange, Julie Toubiana, Perrine Parize, Florence Moulin, Anne Scemla, and Marianne Leruez-Ville
- Subjects
Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Objective: To compare the burden of nosocomial and community-acquired respiratory syncytial virus (RSV)-associated acute lower respiratory tract infections (ALRIs) in adult and pediatric patients concomitantly admitted to a French tertiary hospital, and to evaluate the effectiveness of existing infection control measures. Patients and methods: We prospectively included all adult and pediatric patients admitted to Necker hospital (Paris) between October 2018 and February 2019 with a diagnosis of RSV-associated ALRI. We compared characteristics of ALRIs between patients with community-acquired versus nosocomial infections and, in each group, between children and adults. Results: Community-acquired and nosocomial RSV-associated ALRIs were diagnosed in 229 and 11 inpatients, respectively. The burden of community-acquired infections was higher in children than in adults: 2.1% versus 0.2% of the total number of pediatric and adult inpatients, respectively (p
- Published
- 2020
- Full Text
- View/download PDF
38. Prise en charge du patient neutropénique en réanimation (nouveau-nés exclus). Recommandations d’un panel d’experts de la Société de réanimation de langue française (SRLF) avec le Groupe francophone de réanimation et urgences pédiatriques (GFRUP), la Société française d’anesthésie et de réanimation (Sfar), la Société française d’hématologie (SFH), la Société française d’hygiène hospitalière (SF2H) et la Société de pathologies infectieuses de langue française (SPILF)
- Author
-
Schnell, D., Azoulay, E., Benoit, D., Clouzeau, B., Demaret, P., Ducassou, S., Frange, P., Lafaurie, M., Legrand, M., Meert, A.-P., Mokart, D., Naudin, J., Pène, F., Rabbat, A., Raffoux, E., Ribaud, P., Richard, J.-C., Vincent, F., Zahar, J.-R., and Darmon, M.
- Abstract
La neutropénie est définie par une baisse du nombre absolu de polynucléaires ou par une dysfonction de ces derniers. Elle est source de complications pouvant nécessiter une admission en réanimation. Les spécificités de prise en charge des patients neutropéniques admis en réanimation ont motivé ce référentiel. Ces recommandations ont été réalisées sous l’égide de la Société de réanimation de langue française (SRLF) par un panel d’experts choisis au sein de la SRLF, du Groupe francophone de réanimation et d’urgences pédiatriques (GFRUP), de la Société française d’anesthésie et de réanimation (Sfar), de la Société française d’hématologie (SFH), de la Société française d’hygiène hospitalière (SF2H) et de la Société de pathologie infectieuse de langue française (SPILF). L’analyse du niveau de preuve et la formulation des recommandations ont suivi la méthode « GRADE » (grading of recommendations assessment, development and evaluation system). Les recommandations ont été cotées selon la méthode RAND/UCLA. Six champs ont été définis : 1) admission en réanimation et pronostic ; 2) isolement et prophylaxies ; 3) diagnostic des complications respiratoires ; 4) prise en charge des complications viscérales ; 5) traitements anti-infectieux : antibiothérapie et contrôle de la source ; 6) prise en charge hématologique. La plupart des recommandations sont de bas niveau de preuve, soulignant les besoins d’études spécifiques dans cette population. Cependant, sept recommandations de haut niveau de preuve ont pu être formulées concernant l’isolement protecteur, la stratégie diagnostique de l’insuffisance respiratoire aiguë, la prise en charge médicale et le délai de la chirurgie de l’entérocolite du neutropénique. Neutropenia is defined either by an absolute or functional defect (acute myeloid leukemia or myelodysplastic syndrome) of polymorphonuclear neutrophils and is associated with high risk of specific complications that may require intensive care unit (ICU) admission. Specificities in the management of critically ill neutropenic patients prompted the establishment of guidelines dedicated to intensivists. These recommendations were drawn up by a panel of experts brought together by the French Intensive Care Society (SRLF) in collaboration with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Literature review and formulation of recommendations were performed using the Grading of Recommendations Assessment, Development and Evaluation (“GRADE”) system. Each recommendation was then evaluated and rated by each expert using a methodology derived from the RAND/UCLA Appropriateness Method. Six fields are covered by the provided recommendations: 1) ICU admission and prognosis; 2) protective isolation and prophylaxis; 3) management of acute respiratory failure; 4) organ failure and organ support; 5) antibiotic management and source control; and 6) hematological management. Most of the provided recommendations are obtained from low levels of evidence, however, suggesting a need for additional studies. Seven recommendations were however associated with high level of evidences and are related to protective isolation, diagnostic workup of acute respiratory failure, medical management and timing of surgery in patients with typhlitis.
- Published
- 2024
- Full Text
- View/download PDF
39. Nouvelles perspectives thérapeutiques dans l’infection à cytomégalovirus
- Author
-
Frange, P. and Leruez-Ville, M.
- Published
- 2017
- Full Text
- View/download PDF
40. Recent actuality about Bacillus cereus and human milk bank: a new sensitive method for microbiological analysis of pasteurized milk
- Author
-
Rigourd, V., Barnier, J. P., Ferroni, A., Nicloux, M., Hachem, T., Magny, J. F., Lapillonne, A., Frange, P., Nassif, X., and Bille, E.
- Published
- 2018
- Full Text
- View/download PDF
41. Impaired telomere integrity and rRNA biogenesis in PARN‐deficient patients and knock‐out models
- Author
-
Maname Benyelles, Harikleia Episkopou, Marie‐Françoise O'Donohue, Laëtitia Kermasson, Pierre Frange, Florian Poulain, Fatma Burcu Belen, Meltem Polat, Christine Bole‐Feysot, Francina Langa‐Vives, Pierre‐Emmanuel Gleizes, Jean‐Pierre deVillartay, Isabelle Callebaut, Anabelle Decottignies, and Patrick Revy
- Subjects
Høyeraal–Hreidarsson syndrome ,p53 ,PARN ,rRNA ,shelterin ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Abstract PARN, poly(A)‐specific ribonuclease, regulates the turnover of mRNAs and the maturation and stabilization of the hTR RNA component of telomerase. Biallelic PARN mutations were associated with Høyeraal–Hreidarsson (HH) syndrome, a rare telomere biology disorder that, because of its severity, is likely not exclusively due to hTR down‐regulation. Whether PARN deficiency was affecting the expression of telomere‐related genes was still unclear. Using cells from two unrelated HH individuals carrying novel PARN mutations and a human PARN knock‐out (KO) cell line with inducible PARN complementation, we found that PARN deficiency affects both telomere length and stability and down‐regulates the expression of TRF1, TRF2, TPP1, RAP1, and POT1 shelterin transcripts. Down‐regulation of dyskerin‐encoding DKC1 mRNA was also observed and found to result from p53 activation in PARN‐deficient cells. We further showed that PARN deficiency compromises ribosomal RNA biogenesis in patients' fibroblasts and cells from heterozygous Parn KO mice. Homozygous Parn KO however resulted in early embryonic lethality that was not overcome by p53 KO. Our results refine our knowledge on the pleiotropic cellular consequences of PARN deficiency.
- Published
- 2019
- Full Text
- View/download PDF
42. Artista.Professora.Pesquisadora em continuum
- Author
-
Lucimar Bello Pereira Frange
- Subjects
Fine Arts ,Arts in general ,NX1-820 ,Visual arts ,N1-9211 - Abstract
Ser e Estar mergulhada em estados de criação tem sido há anos, uma escolha fundante. Invento ao mesmo tempo palavras, imagens e proposições artísticas. Nesse artigo recorto parte dessa produção e faço elos entre o Poema IX do livro de poemas Caracol é uma casa que se anda e Ações Performáticas – A Casa Vestida. O tema central, em ambos, é a CASA em sentido bastante ampliado. Dialogo com escritores, filósofos, artistas e arte educadores. Neles ancoro minhas inquietações e os modos de ativar miúdos do mundo para que virem formas potentes de arte em vidas acesas.
- Published
- 2019
- Full Text
- View/download PDF
43. 'Real life' use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.
- Author
-
Pierre Gantner, Babacar Sylla, Laurence Morand-Joubert, Pierre Frange, Karine Lacombe, Marie-Aude Khuong, Claudine Duvivier, Odile Launay, Marina Karmochkine, Cédric Arvieux, Amélie Ménard, Lionel Piroth, Ana Canestri, Dominique Trias, Gilles Peytavin, Roland Landman, Jade Ghosn, and Coferal-IMEA048 Study Group
- Subjects
Medicine ,Science - Abstract
IntroductionLimited "real life" data on raltegravir (RAL) use during pregnancy are available. Thus, we aimed at describing effectiveness and safety of RAL-based combined antiretroviral therapy (cART) in this setting.MethodsHIV-1-infected women receiving RAL during pregnancy between 2008 and 2014 in ten French centers were retrospectively analysed for: (1) proportion of women receiving RAL anytime during pregnancy who achieved a plasma HIV-RNA (pVL) < 50 copies/mL at delivery, and (2) description of demographics, immuno-virological parameters and safety in women and new-borns.ResultsWe included 94 women (median age, 33 years) of which 85% originated from Sub-Saharan Africa and 16% did not have regular health insurance coverage. Sixteen women were cART-naïve (median HIV diagnosis at 30 weeks of gestation), whereas 78 were already on cART before pregnancy (40% with pVL < 50 copies/mL). RAL was initiated before pregnancy (n = 33), during the second trimester (n = 11) and the third trimester of pregnancy (n = 50). No RAL discontinuations due to adverse events were observed. Overall, at the time of delivery, pVL was < 50 copies/mL in 70% and < 400 copies/mL in 84% of women. Specifically, pVL at delivery was < 50 copies/mL in 82%, 55% and 56% of cases when RAL was started before pregnancy, during the second or third trimester of pregnancy, respectively. Median term was 38 weeks of gestation, no defect was reported and all new-borns were HIV non-infected at Month 6.ConclusionsRAL appears safe and effective in this "real-life" study. No defect and no HIV transmission was reported in new-borns.
- Published
- 2019
- Full Text
- View/download PDF
44. VIH
- Author
-
Haas, H., primary, Pinto-Cardoso, G., additional, Pinquier, D., additional, and Frange, P., additional
- Published
- 2018
- Full Text
- View/download PDF
45. An update on pediatric invasive aspergillosis
- Author
-
Frange, P., Bougnoux, M.-E., Lanternier, F., Neven, B., Moshous, D., Angebault, C., Lortholary, O., and Blanche, S.
- Published
- 2015
- Full Text
- View/download PDF
46. Prise en charge du patient neutropénique en réanimation (nouveau-nés exclus). Recommandations d’un panel d’experts de la Société de réanimation de langue française (SRLF) avec le Groupe francophone de réanimation et urgences pédiatriques (GFRUP), la Société française d’anesthésie et de réanimation (Sfar), la Société française d’hématologie (SFH), la Société française d’hygiène hospitalière (SF2H) et la Société de pathologies infectieuses de langue française (SPILF)
- Author
-
Schnell, D., Azoulay, E., Benoit, D., Clouzeau, B., Demaret, P., Ducassou, S., Frange, P., Lafaurie, M., Legrand, M., Meert, A.-P., Mokart, D., Naudin, J., Pène, F., Rabbat, A., Raffoux, E., Ribaud, P., Richard, J.-C., Vincent, F., Zahar, J.-R., and Darmon, M.
- Published
- 2017
- Full Text
- View/download PDF
47. Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
- Author
-
Ilhem Rahal, Claire Galambrun, Yves Bertrand, Nathalie Garnier, Catherine Paillard, Pierre Frange, Corinne Pondarré, Jean Hugues Dalle, Regis Peffault de Latour, Mauricette Michallet, Dominique Steschenko, Despina Moshous, Patrick Lutz, Jean Louis Stephan, Pierre Simon Rohrlich, Ibrahim Yakoub-Agha, Françoise Bernaudin, Christophe Piguet, Nathalie Aladjidi, Catherine Badens, Claire Berger, Gérard Socié, Cécile Dumesnil, Marie Pierre Castex, Marilyne Poirée, Anne Lambilliotte, Caroline Thomas, Pauline Simon, Pascal Auquier, Gérard Michel, Anderson Loundou, Imane Agouti, and Isabelle Thuret
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
In this retrospective study, we evaluate long-term complications in nearly all β-thalassemia-major patients who successfully received allogeneic hematopoietic stem cell transplantation in France. Ninety-nine patients were analyzed with a median age of 5.9 years at transplantation. The median duration of clinical follow up was 12 years. All conditioning regimens were myeloablative, most were based on busulfan combined with cyclophosphamide, and more than 90% of patients underwent a transplant from a matched sibling donor. After transplantation, 11% of patients developed thyroid dysfunction, 5% diabetes, and 2% heart failure. Hypogonadism was present in 56% of females and 14% of males. Female patients who went on to normal puberty after transplant were significantly younger at transplantation than those who experienced delayed puberty (median age 2.5 vs. 8.7 years). Fertility was preserved in 9 of 27 females aged 20 years or older and 2 other patients became pregnant following oocyte donation. In addition to patient’s age and higher serum ferritin levels at transplantation, time elapsed since transplant was significantly associated with decreased height growth in multivariate analysis. Weight growth increased after transplantation particularly in females, 36% of adults being overweight at last evaluation. A comprehensive long-term monitoring, especially of endocrine late effects, is required after hematopoietic stem cell transplantation for thalassemia.
- Published
- 2018
- Full Text
- View/download PDF
48. Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015.
- Author
-
Violaine Corbin, Pierre Frange, Florence Veber, Stéphane Blanche, Camille Runel-Belliard, Muriel Lalande, Virginie Gandemer, Marie Moukagni-Pelzer, Catherine Dollfus, Dilek Coban, Justine Prouteau, Christine Jacomet, Olivier Lesens, and HIV adopted children study group
- Subjects
Medicine ,Science - Abstract
OBJECTIVE(S):To describe the clinical, virological and immune characteristics of internationally adopted children on arrival in France and after 6-months follow-up. DESIGN:Multicenter retrospective study. METHODS:30 centers from 24 cities were asked to include, after informed consent, HIV+ children living in France and internationally adopted between 1st Jan 2005 and 1st Jan 2015. Sociodemographic, medical and biological variables collected during the first medical evaluation in France and 6 months later were analyzed. RESULTS:41 HIV+ adoptees were included (female: 56%; median age: 3.91 years) in 14 centers. Adoptees tend to represent an increasing part of newly diagnosed HIV positive children over the years. The majority came from East-Asia. At arrival, one child was diagnosed with lymphobronchial tuberculosis and three with latent chronic hepatitis B, cleared HBV infection and chronic active hepatitis C, respectively. The mean CD4% was 32.8 ± 9% (range: 13-49%). The 34 children (83%) have been initiated on treatment from their countries of origin. Of these, 25 (74%) had an undetectable viral load (VL) on arrival. Resistance to ART was detected in five. At 6 months, 36 adoptees received ART, and the VL was undetectable in 29 children (71%), with one acquired resistance to NRTI & NNRTI. CONCLUSIONS:An increasing number of HIV-infected children have been internationally adopted in France since 2005. Most of the children have been initiated on treatment from their countries of origin, had good immunity, with few opportunistic infections, and infrequently detectable VL. Low level of mutation conferring resistance was detected.
- Published
- 2018
- Full Text
- View/download PDF
49. The Importance of Sleep for Successful Neurorehabilitation after Stroke
- Author
-
Frange, Cristina, Murray, Brian James, and Coelho, Fernando Morgadinho Santos
- Published
- 2023
- Full Text
- View/download PDF
50. Traitements antiviraux de l’infection sévère à cytomégalovirus – état des lieux et perspectives
- Author
-
Frange, P. and Leruez-Ville, M.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.